Nuveen Asset Management, LLC Revolution Medicines, Inc. Transaction History

Nuveen Asset Management, LLC

$345 Billion
Q3 2024

A detailed history of Nuveen Asset Management, LLC transactions in Revolution Medicines, Inc. stock. As of the latest transaction made, Nuveen Asset Management, LLC holds 459,337 shares of RVMD stock, worth $25.9 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares

459,337

Previous 455,132 0.92%

Holding current value

$25.9 Million

Previous $17.7 Million 17.83%

% of portfolio

0.01%

Previous 0.01%

19 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$36.92 - $47.94 $155,248 - $201,587	4,205 Added 0.92%	459,337 $20.8 Million
Q2 2024 Aug 09, 2024	BUY	$30.14 - $40.68 $2.45 Million - $3.31 Million	81,357 Added 21.77%	455,132 $17.7 Million
Q1 2024 May 13, 2024	SELL	$26.56 - $33.55 $289,318 - $365,460	-10,893 Reduced 2.83%	373,775 $12 Million
Q4 2023 Feb 14, 2024	BUY	$18.35 - $34.12 $2.01 Million - $3.74 Million	109,723 Added 39.91%	384,668 $11 Million
Q3 2023 Nov 14, 2023	SELL	$25.17 - $35.05 $61,540 - $85,697	-2,445 Reduced 0.88%	274,945 $7.61 Million
Q2 2023 Aug 14, 2023	BUY	$20.28 - $27.0 $782,179 - $1.04 Million	38,569 Added 16.15%	277,390 $7.42 Million
Q1 2023 May 15, 2023	BUY	$20.76 - $30.09 $782,008 - $1.13 Million	37,669 Added 18.73%	238,821 $5.17 Million
Q4 2022 Feb 14, 2023	SELL	$17.68 - $25.53 $547,231 - $790,204	-30,952 Reduced 13.34%	201,152 $4.79 Million
Q3 2022 Nov 14, 2022	BUY	$17.46 - $26.0 $359,885 - $535,912	20,612 Added 9.75%	232,104 $4.58 Million
Q2 2022 Aug 15, 2022	BUY	$14.54 - $27.17 $36,698 - $68,577	2,524 Added 1.21%	211,492 $4.12 Million
Q1 2022 May 16, 2022	SELL	$17.31 - $26.4 $123,749 - $188,733	-7,149 Reduced 3.31%	208,968 $4.34 Million
Q4 2021 Feb 14, 2022	SELL	$24.35 - $33.7 $3.07 Million - $4.25 Million	-126,158 Reduced 36.86%	216,117 $5.44 Million
Q3 2021 Nov 12, 2021	SELL	$23.95 - $33.41 $663,534 - $925,624	-27,705 Reduced 7.49%	342,275 $9.42 Million
Q2 2021 Aug 16, 2021	BUY	$29.0 - $47.44 $4.72 Million - $7.71 Million	162,602 Added 78.41%	369,980 $11.7 Million
Q1 2021 May 17, 2021	BUY	$37.21 - $54.43 $2.03 Million - $2.97 Million	54,518 Added 35.67%	207,378 $9.52 Million
Q4 2020 Feb 16, 2021	BUY	$30.19 - $45.49 $21,525 - $32,434	713 Added 0.47%	152,860 $6.05 Million
Q3 2020 Nov 16, 2020	BUY	$22.61 - $34.8 $524,778 - $807,707	23,210 Added 18.0%	152,147 $5.29 Million
Q2 2020 Aug 14, 2020	BUY	$19.65 - $39.34 $950,116 - $1.9 Million	48,352 Added 60.0%	128,937 $4.07 Million
Q1 2020 May 14, 2020	BUY	$20.0 - $34.08 $1.61 Million - $2.75 Million	80,585 New	80,585 $1.77 Million

Others Institutions Holding RVMD

# of Institutions

266

Shares Held

161M

Call Options Held

260K

Put Options Held

620K

View Full List

About Revolution Medicines, Inc.

Ticker RVMD
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,697,600
Market Cap $4.95B
Description
Revolution Medicines, Inc., a clinical-stage precision oncology company, focuses on developing therapies to inhibit frontier targets in RAS-addicted cancers. The company is developing RMC-4630, an inhibitor of SHP2, which is in Phase 1/2 clinical trial for the treatment of solid tumors, such as gynecologic and colorectal cancer tumors. It also d...

More about RVMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nuveen Asset Management, LLC with notifications on news.

Account

Nuveen Asset Management, LLC Revolution Medicines, Inc. Transaction History